Chen Yin-Yin, Wang Fu-Der, Liu Cheng-Yi, Chou Pesus
Department of Infection Control, Taipei Veterans General Hospital, and the Community Medicine Research Center and Institute of Public Health, the School of Nursing, National Yang-Ming University, Taipei, Taiwan, Republic of China.
Infect Control Hosp Epidemiol. 2009 Jan;30(1):39-46. doi: 10.1086/592984.
Nosocomial infection (NI) is one of the most serious healthcare issues currently influencing healthcare costs. This study estimates the impact of NI on costs in intensive care units (ICUs).
Prospective surveillance by a retrospective cohort study.
A medical ICU, a surgical ICU, and a mixed medical and surgical ICU in a large tertiary referral medical center.
Surveillance for NIs was conducted for all patients admitted to adult ICUs from 2003 through 2005. Retrospective chart review was conducted for each patient. The generalized linear modeling approach was used to assess the relationship of NIs to the increase in variable costs in individual ICUs and in all ICUs.
A total of 401 NIs occurred in 320 of 2,757 screened patients. The incidence rate was 12.1% in the medical ICU, 14.7% in the surgical ICU, and 16.7% in the mixed medical and surgical ICU (P>.05). All of the mean variable costs were significantly higher for patients with NI than they were for patients without NI, after controlling for covariates. The medical ICU had the greatest increase in mean cost ($13,456, which was 3.52 times [95% confidence interval {CI}, 2.94-4.22 times] the mean cost for patients without NI), followed by the mixed medical and surgical ICU ($6,748, which was 2.74 times [95% CI, 2.33-3.22 times] the mean cost for patients without NI) and the surgical ICU ($5,433, which was 2.46 times [95% CI, 1.99-3.05 times] the mean cost for patients without NI). Mean cost increases according to the site of NI were $6,056 for bloodstream infection (2.36 times [95% CI, 1.97-2.84 times] the mean cost for patients without NI), $4,287 for respiratory tract infection (1.91 times [95% CI, 1.57-2.32 times] the mean cost for patients without NI), $1,955 for urinary tract infection (1.42 times [95% CI, 1.18-1.72 times] the mean cost for patients without NI), and $1,051 for surgical site infection (1.23 times [95% CI, 0.90-1.68 times] the mean cost for patients without NI).
The medical ICU had the lowest rate of NI and the largest excess costs, the surgical ICU had the lowest excess costs, and the mixed medical and surgical ICU had the highest rate of NI. The cost is largely attributable to bloodstream infection and respiratory tract infection.
医院感染(NI)是当前影响医疗成本的最严重医疗问题之一。本研究评估了NI对重症监护病房(ICU)成本的影响。
回顾性队列研究的前瞻性监测。
一家大型三级转诊医疗中心的一个内科ICU、一个外科ICU以及一个内科和外科混合ICU。
对2003年至2005年入住成人ICU的所有患者进行NI监测。对每位患者进行回顾性病历审查。采用广义线性建模方法评估NI与各个ICU以及所有ICU可变成本增加之间的关系。
在2757例筛查患者中的320例中共发生了401例NI。内科ICU的发病率为12.1%,外科ICU为14.7%,内科和外科混合ICU为16.7%(P>0.05)。在控制协变量后,所有NI患者的平均可变成本均显著高于无NI患者。内科ICU的平均成本增加最多(13456美元,是无NI患者平均成本的3.52倍[95%置信区间{CI},2.94 - 4.22倍]),其次是内科和外科混合ICU(6748美元,是无NI患者平均成本的2.74倍[95%CI,2.33 - 3.22倍])和外科ICU(5433美元,是无NI患者平均成本的2.46倍[95%CI,1.99 - 3.05倍])。根据NI发生部位,血流感染的平均成本增加为6056美元(是无NI患者平均成本的2.36倍[95%CI,1.97 - 2.84倍]),呼吸道感染为4287美元(1.91倍[95%CI,1.57 - 2.32倍]),尿路感染为1955美元(1.42倍[95%CI,1.18 - 1.72倍]),手术部位感染为1051美元(1.23倍[95%CI,0.90 - 1.68倍])。
内科ICU的NI发生率最低但额外成本最高,外科ICU的额外成本最低,内科和外科混合ICU的NI发生率最高。成本主要归因于血流感染和呼吸道感染。